Literature DB >> 23784856

Development and validation of an assay to detect porcine reproductive and respiratory syndrome virus-specific neutralizing antibody titers in pig oral fluid samples.

Kang Ouyang1, Basavaraj Binjawadagi, Apisit Kittawornrat, Chris Olsen, Jagadish Hiremath, Nadia Elkalifa, Rose Schleappi, Jianmin Wu, Jeffrey Zimmerman, Gourapura J Renukaradhya.   

Abstract

Porcine reproductive and respiratory syndrome virus (PRRSV)-specific neutralizing antibodies (NA) are important for clearing the virus. Pen-based pig oral fluid samples for disease surveillance are gaining in importance due to the ease of collection and low cost. The aim of this study was to develop a PRRSV-specific NA assay to determine NA titers in pig oral fluid samples. At first, we standardized the PRRSV NA assay using pen-based pig oral fluid samples collected over a period of 3 months from a herd of swine that received a PRRSV modified live vaccine (PRRS-MLV), and we also used oral fluid and serum samples collected from individual boars that were vaccinated with PRRS-MLV or infected with a virulent PRRSV strain. Our results suggest that a PRRSV NA titer of >8 in oral fluid samples is virus specific and can be detected beginning at 28 days after vaccination or infection. To validate the assay, we used 104 pen-based pig oral fluid and five representative serum samples from each pen of unknown history, as well as 100 serum samples from repeatedly vaccinated sows and oral fluid samples of their respective litters belonging to four different swine-breeding farms. Our results demonstrated that PRRSV NA titers in oral fluid samples are correlated with serum sample titers, and maternally derived PRRSV-specific NA titers could be detected in litters at the time of weaning. In conclusion, we have standardized and validated the pig oral fluid-based PRRSV NA assay, which has 94.3% specificity and 90.5% repeatability. The assay can be used to monitor herd immunity against PRRSV in vaccinated and infected herds of swine.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23784856      PMCID: PMC3754528          DOI: 10.1128/CVI.00276-13

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  37 in total

Review 1.  Epidemiology of porcine reproductive and respiratory syndrome (PRRS): an overview.

Authors:  E Albina
Journal:  Vet Microbiol       Date:  1997-04       Impact factor: 3.293

Review 2.  Role of neutralizing antibodies in PRRSV protective immunity.

Authors:  O J Lopez; F A Osorio
Journal:  Vet Immunol Immunopathol       Date:  2004-12-08       Impact factor: 2.046

3.  Characterization of swine infertility and respiratory syndrome (SIRS) virus (isolate ATCC VR-2332).

Authors:  D A Benfield; E Nelson; J E Collins; L Harris; S M Goyal; D Robison; W T Christianson; R B Morrison; D Gorcyca; D Chladek
Journal:  J Vet Diagn Invest       Date:  1992-04       Impact factor: 1.279

4.  Effect of genotypic and biotypic differences among PRRS viruses on the serologic assessment of pigs for virus infection.

Authors:  Won-Il Kim; Du-Sik Lee; Wesley Johnson; Mike Roof; Sang-Ho Cha; Kyoung-Jin Yoon
Journal:  Vet Microbiol       Date:  2007-03-27       Impact factor: 3.293

5.  Prolonged detection of PCV2 and anti-PCV2 antibody in oral fluids following experimental inoculation.

Authors:  J R Prickett; J Johnson; M P Murtaugh; S Puvanendiran; C Wang; J J Zimmerman; T Opriessnig
Journal:  Transbound Emerg Dis       Date:  2011-01-11       Impact factor: 5.005

6.  Pathogenesis of rinderpest virus infection in rabbits. II. Effect of rinderpest virus on the immune functions of rabbits.

Authors:  K Yamanouchi; A Fukuda; F Kobune; Y Yoshikawa; F Chino
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

7.  Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro.

Authors:  J Schlender; J J Schnorr; P Spielhoffer; T Cathomen; R Cattaneo; M A Billeter; V ter Meulen; S Schneider-Schaulies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

8.  Comparison of commercial real-time reverse transcription-PCR assays for reliable, early, and rapid detection of heterologous strains of porcine reproductive and respiratory syndrome virus in experimentally infected or noninfected boars by use of different sample types.

Authors:  Priscilla F Gerber; Kevin O'Neill; Olajide Owolodun; Chong Wang; Karen Harmon; Jianqiang Zhang; Patrick G Halbur; Lei Zhou; Xiang-Jin Meng; Tanja Opriessnig
Journal:  J Clin Microbiol       Date:  2012-12-05       Impact factor: 5.948

9.  Mechanism of measles virus-induced suppression of inflammatory immune responses.

Authors:  J C Marie; J Kehren; M C Trescol-Biémont; A Evlashev; H Valentin; T Walzer; R Tedone; B Loveland; J F Nicolas; C Rabourdin-Combe; B Horvat
Journal:  Immunity       Date:  2001-01       Impact factor: 31.745

Review 10.  Innate antiviral defenses in body fluids and tissues.

Authors:  S Baron; I Singh; A Chopra; D Coppenhaver; J Pan
Journal:  Antiviral Res       Date:  2000-11       Impact factor: 5.970

View more
  7 in total

1.  Oral fluid samples used for PRRSV acclimatization program and sow performance monitoring in endemic PRRS-positive farms.

Authors:  Yonlayong Woonwong; Roongtham Kedkovid; Jirapat Arunorat; Chaitawat Sirisereewan; Teerawut Nedumpun; Korakrit Poonsuk; Yaowalak Panyasing; Pariwat Poolperm; Alongkot Boonsoongnern; Roongroje Thanawongnuwech
Journal:  Trop Anim Health Prod       Date:  2017-10-05       Impact factor: 1.559

2.  Evaluation of the specificity of a commercial ELISA for detection of antibodies against porcine respiratory and reproductive syndrome virus in individual oral fluid of pigs collected in two different ways.

Authors:  Tatjana Sattler; Eveline Wodak; Friedrich Schmoll
Journal:  BMC Vet Res       Date:  2015-03-19       Impact factor: 2.741

3.  Comparative analysis of routes of immunization of a live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in a heterologous virus challenge study.

Authors:  Kang Ouyang; Jagadish Hiremath; Basavaraj Binjawadagi; Duan-Liang Shyu; Santosh Dhakal; Jesus Arcos; Rose Schleappi; Lynette Holman; Michael Roof; Jordi B Torrelles; Gourapura J Renukaradhya
Journal:  Vet Res       Date:  2016-03-17       Impact factor: 3.683

4.  Comparison of PRRSV Nucleic Acid and Antibody Detection in Pen-Based Oral Fluid and Individual Serum Samples in Three Different Age Categories of Post-Weaning Pigs from Endemically Infected Farms.

Authors:  Nick De Regge; Brigitte Cay
Journal:  PLoS One       Date:  2016-11-07       Impact factor: 3.240

5.  Combined Subcutaneous-Intranasal Immunization With Epitope-Based Antigens Elicits Binding and Neutralizing Antibody Responses in Serum and Mucosae Against PRRSV-2 and SARS-CoV-2.

Authors:  Mario Fragoso-Saavedra; Carmen Ramírez-Estudillo; Diana L Peláez-González; Jorge O Ramos-Flores; Gustavo Torres-Franco; Leandro Núñez-Muñoz; Gabriel Marcelino-Pérez; María G Segura-Covarrubias; Rogelio González-González; Roberto Ruiz-Medrano; Beatriz Xoconostle-Cázares; Amanda Gayosso-Vázquez; Silvia Reyes-Maya; Vianey Ramírez-Andoney; Rogelio A Alonso-Morales; Marco A Vega-López
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 7.561

6.  Differences in Humoral Immune Response against the Type 2 Porcine Reproductive and Respiratory Syndrome Virus via Different Immune Pathways.

Authors:  Wen Li; Yangyang Sun; Shijie Zhao; Zhiying Cui; Yu Chen; Pengli Xu; Jing Chen; Yina Zhang; Pingan Xia
Journal:  Viruses       Date:  2022-06-29       Impact factor: 5.818

7.  Evaluation of humoral immune status in porcine epidemic diarrhea virus (PEDV) infected sows under field conditions.

Authors:  Kang Ouyang; Duan-Liang Shyu; Santosh Dhakal; Jagadish Hiremath; Basavaraj Binjawadagi; Yashavanth S Lakshmanappa; Rui Guo; Russell Ransburgh; Kathryn M Bondra; Phillip Gauger; Jianqiang Zhang; Terry Specht; Aaron Gilbertie; William Minton; Ying Fang; Gourapura J Renukaradhya
Journal:  Vet Res       Date:  2015-12-14       Impact factor: 3.683

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.